Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Clinical trial NCT03684642 · TERMINATED
Trial details
- NCT number
- NCT03684642
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2020-10-13
- Enrollment
- 908
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.